TC BioPharm Holdings Price Prediction
| TCBPDelisted Stock | USD 0.50 0.00 0.00% |
Momentum 27
Sell Stretched
Oversold | Overbought |
Using TC BioPharm hype-based prediction, you can estimate the value of TC BioPharm Holdings from the perspective of TC BioPharm response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in TC BioPharm to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying TCBP because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
TC BioPharm after-hype prediction price | USD 0.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
TCBP |
TC BioPharm After-Hype Price Density Analysis
As far as predicting the price of TC BioPharm at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in TC BioPharm or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of TC BioPharm, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
TC BioPharm Estimiated After-Hype Price Volatility
In the context of predicting TC BioPharm's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on TC BioPharm's historical news coverage. TC BioPharm's after-hype downside and upside margins for the prediction period are 0.50 and 0.50, respectively. We have considered TC BioPharm's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
TC BioPharm is very steady at this time. Analysis and calculation of next after-hype price of TC BioPharm Holdings is based on 3 months time horizon.
TC BioPharm Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as TC BioPharm is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TC BioPharm backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with TC BioPharm, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 5 Events / Month | 1 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.50 | 0.50 | 0.00 |
|
TC BioPharm Hype Timeline
TC BioPharm Holdings is at this time traded for 0.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. TCBP is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on TC BioPharm is about 0.0%, with the expected price after the next announcement by competition of 0.50. The company has price-to-book ratio of 0.06. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. TC BioPharm Holdings recorded a loss per share of 4794.42. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 10th of February 2025. Given the investment horizon of 90 days the next forecasted press release will be in about 5 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.TC BioPharm Related Hype Analysis
Having access to credible news sources related to TC BioPharm's direct competition is more important than ever and may enhance your ability to predict TC BioPharm's future price movements. Getting to know how TC BioPharm's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how TC BioPharm may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFFP | Tff Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SEEL | Seelos Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VIRI | Virios Therapeutics Llc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LSB | LakeShore Biopharma Co | (0.03) | 7 per month | 8.14 | 0.01 | 12.33 | (12.50) | 91.99 | |
| OSA | ProSomnus Common Stock | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BLPH | Bellerophon Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LFLY | Leafly Holdings | 0.00 | 1 per month | 0.00 | (0.09) | 8.11 | (8.41) | 101.74 | |
| PHIO | Phio Pharmaceuticals Corp | (0.02) | 8 per month | 0.00 | (0.24) | 4.88 | (9.27) | 19.15 | |
| IMTX | Immatics NV | 0.1 | 8 per month | 0.00 | (0.03) | 7.31 | (6.47) | 30.34 | |
| HSTO | Histogen | 0.00 | 0 per month | 0.00 | (0.11) | 10.80 | (10.71) | 93.31 |
TC BioPharm Additional Predictive Modules
Most predictive techniques to examine TCBP price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for TCBP using various technical indicators. When you analyze TCBP charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About TC BioPharm Predictive Indicators
The successful prediction of TC BioPharm stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as TC BioPharm Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of TC BioPharm based on analysis of TC BioPharm hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to TC BioPharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to TC BioPharm's related companies.
Pair Trading with TC BioPharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TC BioPharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TC BioPharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TCBP Pink Sheet
Moving against TCBP Pink Sheet
| 0.91 | MRK | Merck Company | PairCorr |
| 0.9 | SAR | Saratoga Investment Corp | PairCorr |
| 0.88 | AA | Alcoa Corp | PairCorr |
| 0.88 | JNJ | Johnson Johnson | PairCorr |
| 0.86 | WMT | Walmart Common Stock Sell-off Trend | PairCorr |
| 0.85 | ACN | Accenture plc | PairCorr |
The ability to find closely correlated positions to TC BioPharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TC BioPharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TC BioPharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TC BioPharm Holdings to buy it.
The correlation of TC BioPharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TC BioPharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TC BioPharm Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TC BioPharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in TCBP Pink Sheet
If you are still planning to invest in TC BioPharm Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TC BioPharm's history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |